• Communication manager

Anders Grönberg to expand focus on accreditation of surgeons and clinical studies

Anders Grönberg is now given more time to focus as Chief Medical Officer in CarpoNovum AB. As earlier, attention is on accreditation of surgeons and to lead clinical studies as part of the market introduction. Furthermore, Anders will work to reduce COGS and adapt C-REX for mass production.

Anders Grönberg also continue to hold his position as CEO of CarpoNovum Clinics Ltd, where the intention is to expand the business further.

Recent Posts

See All

In 2022, CarpoNovum will start a European ​Multicenter Post Market Clinical Follow-up study (outside Sweden) on the C-REX® system.​ ​ As part of this we will be hosting workshops throughout the year.